Company Overview and News

4
TDC : Election of members to the Board of Directors of TDC A/S on 14 May 2018

2018-05-14 globenewswire
Further to the notice convening an extraordinary general meeting on 14 May 2018, it can be stated that the following directors as of today resign from the Board of Directors of TDC A/S:
TDCAY TDCAF MIC APRYF APR APRYY

4
TDC : Valg til bestyrelsen i TDC A/S den 14. maj 2018

2018-05-14 globenewswire
I forlængelse af indkaldelsen til ekstraordinær generalforsamling til afholdelse den 14. maj 2018, kan det oplyses, at følgende bestyrelsesmedlemmer per i dag udtræder af bestyrelsen i TDC A/S:
TDCAY TDCAF MIC APRYF APR APRYY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to LSE:APR / APR ENERGY PLC on message board site Silicon Investor.

Apricus Biosciences Apricus Biosciences Apricus Biosciences CEAPRO INC.----CZO CEAPRO INC.----CZO CEAPRO INC.----CZO
DNAG - DNAPrint Genomics DNAG - DNAPrint Genomics DNAG - DNAPrint Genomics thoughts about Apri thoughts about Apri thoughts about Apri
CLOSED-END FUND u0026 GLOBAL ETFS FORUM - Wednesday, April 25, 2 CLOSED-END FUND u0026 GLOBAL ETFS FORUM - Wednesday, April 25, 2 CLOSED-END FUND u0026 GLOBAL ETFS FORUM - Wednesday, April 25, 2 Business Wire Falls for April Fools Prank, Sues FBNers Business Wire Falls for April Fools Prank, Sues FBNers Business Wire Falls for April Fools Prank, Sues FBNers
Napro Biotherap(npro) Napro Biotherap(npro) Napro Biotherap(npro) AFN---April Fool News AFN---April Fool News AFN---April Fool News
Ceapro Inc. Ceapro Inc. Ceapro Inc. Caprius(CAPR), Breast MRI(former ANMR/MAMO) Caprius(CAPR), Breast MRI(former ANMR/MAMO) Caprius(CAPR), Breast MRI(former ANMR/MAMO)